{
    "pmcid": "9174178",
    "qa_pairs": {
        "What animal was used for immunization to develop high-affinity nanobodies against SARS-CoV-2?": [
            "A llama",
            "A camel",
            "A mouse",
            "A rabbit"
        ],
        "What is the name of the bispecific nanobody developed in the study that showed improved potency and is aerosolizable?": [
            "PiN-31",
            "Nb-12",
            "RBD-5",
            "SARS-2"
        ],
        "What is the primary target for neutralizing antibodies in the development of nanobodies against SARS-CoV-2?": [
            "The receptor-binding domain (RBD) of the spike protein",
            "The nucleocapsid protein",
            "The membrane protein",
            "The envelope protein"
        ],
        "What structural techniques were employed to reveal the epitope classes targeted by the nanobodies?": [
            "Cryo-EM and X-ray crystallography",
            "NMR spectroscopy and mass spectrometry",
            "Atomic force microscopy and fluorescence microscopy",
            "Surface plasmon resonance and circular dichroism"
        ],
        "What technique was used to isolate a large repertoire of high-affinity nanobodies in the study?": [
            "Integrative proteomics",
            "Flow cytometry",
            "Western blotting",
            "ELISA"
        ]
    }
}